대한한의학회지 (The Journal of Korean Medicine)

  • 제42권2호
  • /
  • Pages.72-81
  • /
  • 2021
  • /
  • 1010-0695(pISSN)
  • /
  • 2288-3339(eISSN)
대한한의학회 (The Society of Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

건선의 동서의학적 연구 특징의 비교

Comparison of Research Characteristics in Western, Chinese Traditional Medicine and Korean Medicine on Psoriasis

  • 투고 : 2021.01.21
  • 심사 : 2021.03.16
  • 발행 : 2021.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: We compared research characteristics of western medicine, Chinese medicine and Korean medicine on causes, mechanisms, types, treatments and prevention of psoriasis. Methods: For western medicine, "Psoriasis" was used as keyword on Pubmed, for Chinese medicine, "銀屑病" and "中医" on CNKI (China National Knowledge Infrastructure" and for Korean medicine, "건선" on OASIS. Keyword searches were done for papers and books published after 2010. For Chinese medicine, there were more in-depth searches done for "從血論 (血熱, 血瘀, 血燥)" and "陽虛症". Results: Western medicine puts an emphasis on the foci, and approaches it from molecular and genetic levels based on molecular biology; while it views psoriasis as a disease with multiple possible causes, it ultimately sees it as an inflammation that is immunity-mediated. Western medicine seeks to suppress cytokine in order to prevent and eliminate inflammation at each stage of treatment While they are effective short-term, psoriasis recurs shortly after. Chinese and Korean medicines categorize psoriasis as an internal comprehensive systemic diseases that encompasses the patient's physical and mental characteristics, and defines it as a disease that has many causes and mechanisms such as "血熱, 血瘀, 血燥" and "陽虛". They use herbal medicine, acupuncture, and lifestyle interventions to improve the overall health of the patient in addition to treating psoriasis. Treatments are effective, but it takes relatively longer to see results, and can recur. Conclusion: In order for more progress to happen on psoriasis treatment, each branch of medicine must exchange knowledge and information more frequently.

키워드

참고문헌

  1. Youn JI. Psoriasis-An Atlas of Psoriasis-. 1st ed. Seoul:Korea Medical Book Publishing Company. 1996.
  2. Lewis-Beck C, Abouzaid S, Xie L, Baser O, Kim E. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling. Patient Preference and Adherence. 2013;7:199-205. https://doi.org/10.2147/PPA.S39887
  3. De Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140-147. https://doi.org/10.1046/j.1087-0024.2003.09110.x
  4. Wang R, Ding X, Xie F, Gong L, Yang Y, Wang W, et al. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis. Medicine. 2017;96(50):8677-8677.
  5. Lonnberg AS, Skov L. Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Review of Clinical Immunology. 2017;13(1):37-34.
  6. Korean Dermatology Association. Dermatology. 5th rev. ed. Seoul:Ryo Moon Gak. P. Co. 2008:241.
  7. Woo YR, Cho DH, Park HJ. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis. Int J Mol Sci. 2017;18(12):2684. https://doi.org/10.3390/ijms18122684
  8. Weatherhead SC, Farr PM, Reynolds NJ. Spectral effects of UV on psoriasis. Photochem Photobiol Sci. 2013;12(1):47-53. https://doi.org/10.1039/C2PP25116G
  9. Tremezaygues L, Reichrath J. Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going? Dermatoendocrinol. 2011;3(3):180-186. https://doi.org/10.4161/derm.17534
  10. Bai Y, Yang D, Wang Y, Qu X, Li YW, He JY. Clinical analysis on Quyin Granule in treating blood heat type of psoriasis. China Journal of Leprosy and Skin Diseases. 2007;23(12):1065-1067. https://doi.org/10.3969/j.issn.1009-1157.2007.12.011
  11. Zhang DL, Shi P. 62 cases of Blood Heat Syndrome of Psoriasis Vulgaris treated by Liangxue Xiaoyin Mixture. Chinese Journal of Traditional Medical Science and Technology. 2010;17(2):171-172.
  12. Jing XM, Wu G, Qian N. Clinical observation and perception of Psoriasis Vulgaris treated by Huoxue Xiaoyin Decoction in 100 cases. Nei Mongol Journal of Traditional Chinese Medicine. 2012;10:7.
  13. Zhang YD. Discussion about Fundamental Treatment of Psoriasis. 1st ed. Shanxi:Shanxi Science and Technology Publishing House. 2016.
  14. Zhang YD. The Essence of Psoriasis is Accumulation. Chica Net of Traditional Chinese Medicine. 2011 Jul 22;Academic and Clinical Studies:4.
  15. Song P, Yang L, Wu ZK, Zou YH, Wang YY. Treatment of Psoriasis Vulgaris via New Perspective of Xuanfu Theory. Journal of Beijing University of Traditional Chinese Medicine. 2009;32(2):136-138. https://doi.org/10.3321/j.issn:1006-2157.2009.02.018
  16. Song S, Choi J. A Study on the Trend of World Traditional Medicine and Key Area of Traditional Korean Medicine(TKM) R&D. Korea Journal of Oriental Medicine. 2010;16(1):101-109.
  17. Lee CY. Understanding Current Traditional Korean Medicine - Preliminary Study for Discussion on the Identity Issue of TKM. Korean J Oriental Physiology & Pathology. 2010;24(5):758-769.
  18. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. British Journal of Dermatology. 2000;143(5):969-973. https://doi.org/10.1046/j.1365-2133.2000.03829.x
  19. Stinco G, Trevisan G, Piccirillo F, Pezzetta S, Errichetti E, di Meo N, et al. Pruritus in chronic plaque psoriasis: a questionnaire-based study of 230 Italian patients. Acta dermatovenerologica Croatica. 2014;22(2):122-130.
  20. Hancox JH, Sheridan SC, Feldman SR, Fleischer Jr AB. Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. The International Society of Dermatology. 2004;43:6-11. https://doi.org/10.1111/j.1365-4632.2004.01828.x
  21. Guttman-Yassky E, Krueger JG, Lebwohl MG. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Exp Dermatol. 2018;27(4):409-417. https://doi.org/10.1111/exd.13336
  22. Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. The Lancet. 2018;391(10136):2273-2284. https://doi.org/10.1016/S0140-6736(18)30830-4
  23. Baurecht H, Hotze M, Brand S, Buning C, Cormican P, Corvin A, et al. Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms. The American Journal of Human Genetics 96. 2015:104-120. https://doi.org/10.1016/j.ajhg.2014.12.004
  24. Brito-Luna MJ, Villanueva-Quintero DG, Sandoval-Talamantes AK, Fafutis-Morris M, Graciano-Machuca O, Sanchez-Hernandez PE, Alvarado-Navarro A. Correlation of IL-12, IL-22, and IL-23 in patients with psoriasis and metabolic syndrome-Preliminary report. Cytokine (Online). 2016;85:130-136. https://doi.org/10.1016/j.cyto.2016.06.020
  25. Furiati SC, Catarino JS, Silva MV, Silva RF, Estevam RB, Teodoro RB, et al. Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients. Scientific Reportsvolume 9. 2019;9(1):7526. https://doi.org/10.1038/s41598-019-43899-9
  26. Moussali H, Bylaite M, Welss T, Abts HF, Ruzicka T, Walz M. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas. Experimental Dermatology. 2005;14(6):420-428. https://doi.org/10.1111/j.0906-6705.2005.00300.x
  27. Jin L, Wang G. Keratin 17: A Critical Player in the Pathogenesis of Psoriasis. Medicinal Research Reviews. 2014;34(2):438-454. https://doi.org/10.1002/med.21291
  28. Becatti M, Barygina V, Mannucci A, Emmi G, Prisco D, Lotti T, et al. Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis. International Journal of Molecular Sciences. 2018;19(6):1572. https://doi.org/10.3390/ijms19061572
  29. Lee YH, Song GG. Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: a meta-analysis. Clinical and Experimental Dermatology. 2018;43:529-535. https://doi.org/10.1111/ced.13381
  30. Kang DW, Han CY, Kim JD, Kim KS, Kim YB. A Proposal and Considerations for Treatment Approaches of Psoriasis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2020;33(3):99-114. https://doi.org/10.6114/JKOOD.2020.33.3.099
  31. Reali E, Brembilla NC. Editorial: Immunology of Psoriatic Disease. Front Immunol. 2019;10:657. https://doi.org/10.3389/fimmu.2019.00657
  32. Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. The Journal of Allergy and Clinical Immunology. 2017;140(3):645-653. https://doi.org/10.1016/j.jaci.2017.07.004
  33. Eberle FC, Bruck J, Holstein J, Hirahara K, Ghoreschi K. Recent advances in understanding psoriasis. 2016;5:F1000.
  34. Sbidian E, Mezzarobba M, Weill A, Coste J, Rudant J. Persistence of treatment with biologics for patients with psoriasis: A Real-World Analysis of 16,545 biologic-naive patients from the French national health insurance database (SNIIRAM). Br J Dermatol. 2019;180(1):86-93. https://doi.org/10.1111/bjd.16809
  35. Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278-285.
  36. Mudigonda T, Dabade TS, Feldman SR. A review of targeted ultraviolet B phototherapy for psoriasis. J Am Acad Dermatol. 2011;66(4):664-672. https://doi.org/10.1016/j.jaad.2011.07.011
  37. Reichrath J, Saternus R, Vogta T. Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases. The Royal Society of Chemistry and Owner Societies. 2017;16:433-444.
  38. Ford AR, Siegel M, Bagel J, Cordoro KM, Garg A, Gottlieb A, et al. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation A Systematic Review. JAMA Dermatol. 2018;154(8):934-950. https://doi.org/10.1001/jamadermatol.2018.1412
  39. Kim JH. Orignal Article : A Comparative Research of Eight Principle Pattern Identification - based on Zhang Jie-Bin, Cheng Guo-Peng, and Jiang Han-Tun -. Journal of Oriental Medical Classics. 2013;26(2):47-59.
  40. Han JM, Yang WM. A Review on Korean Medicine and Personalized Medicine: Syndrome -based Personalized Medicine on the Basis of Syndrome Differentiation and Treatment. J Korean Med. 2014;35(3):40-48. https://doi.org/10.13048/jkm.14029
  41. Na CS, Jang GS, Sin YI, Kim JS, Hwang UJ. A clinical study according to Jang-Bu-Peon-Zheng. J Korean Med. 1994;15(2)28:143-155.
  42. Cho EC, Kim KS. A Review on Patterns and Classification Criteria of Psoriasis by analyzing Chinese Theses. J Korean Med Ophthalmol Otolaryngol Dermatol. 2020;33(2):112-129. https://doi.org/10.6114/JKOOD.2020.33.2.112
  43. Lu CJ, Guo J. Exploration of the Nature of Psoriasis: Asthenia in Origin and Sthenia in Superficiality. Journal of Traditional Chinese Medicine. 2016;57(20):1735-1740.
  44. Song P, Wu ZK, Zou YH, Wang YY. New Ideas and Exploration of TCM syndrome differentiation and detoxification on Psoriasis Vulgaris. Chinese Journal of Information on Traditional Chinese Medicine. 2009;16(12):90-91. https://doi.org/10.3969/j.issn.1005-5304.2009.12.050
  45. Baik YS. A Study on The Changes of Concept of Syndrome Differentiation in The History of Traditional Medicine -Focusing on meaning and process-. J Korean Medical Classics. 2014;27(4):133-151. https://doi.org/10.14369/skmc.2014.27.4.133
  46. Fang X. Psoriasis. China Medical Science Press. 2009
  47. Zhang YD, Treatment of Psoriasis Vulgaris with "Classical Prescription Eliminating Pathogenic Factor". Interational(China Korea Japan) Conference of Classical Prescription-The second National Classical Prescription Forum and Advanced Apply Research Essays Collection. 2011;05-26:172-191.
  48. Jinrong Zeng, Shuaihantian Luo, Yumeng Huang, Qianjin Lu. Critical role of environmental factors in the pathogenesis of psoriasis. Journal of Dermatology 2017;44:863-872. https://doi.org/10.1111/1346-8138.13806
  49. Singh RK, Lee KM, Jose MV, Nakamura M, Ucmak D, Farahnik B, et al. The Patient's Guide to Psoriasis Treatment. Part 1: UVB Phototherapy. Dermatology and Therapy. 2016;6(3):307-313. https://doi.org/10.1007/s13555-016-0129-2
  50. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. Journal of Autoimmunity. 2010;34:314-321.
  51. Ammar-Khodja A, Benkaidali I, Bouadjar B, Serradj A, Titi A, Benchikhi H, et al. EPIMAG: International Cross-Sectional Epidemiological Psoriasis Study in the Maghreb. Dermatology. 2015;231:134-144. https://doi.org/10.1159/000382123
  52. Park SJ. The Body(Mom) in East Asian Medicine. Philosophy of Medicine. 2006;2:35-5
  53. Lee SY. What Should We do with Korea's Biomedical Model of Medicine? - From Biomedical to Biopsychosocial Model. Korean Journal of Psychosomatic Medicine. 2012;20(1):3-8.
  54. Lee EH. The Principles of Sasang Constitutional Medicine. Seoul:Tasan Cultural Foundation. 2015.
  55. Kim JY, Kim WJ. Comparative Study of Oriental and Western Medicine. 2nd rev. ed. Seoul:Gyechuk Munwhasa. 1994.
  56. Park YB, Kim TH. Syndrome Differentiation and Diagnostics. 1st ed. Seoul:Seongbosa. 1995.